tradingkey.logo
tradingkey.logo
Search

Lantern Pharma Inc

LTRN
Add to Watchlist
2.630USD
-0.020-0.75%
Close 07-31 16:00ETQuotes delayed by 15 min
29.60MMarket Cap
LossP/E TTM

LTRN Financials

See Lantern Pharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Lantern Pharma Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.30/-0.36
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.57
18.65%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
29.67%-0.30
33.16%-0.36
7.88%-0.39
12.88%-0.40
16.94%-0.42
-40.54%-0.54
-43.76%-0.42
-5.44%-0.46
-42.17%-0.51
-24.48%-0.39
---0.29
---0.44
---0.36
---0.31
---1.00
----
----
----
----
----
Net Profit
26.62%-3.33M
30.65%-4.07M
7.29%-4.18M
12.67%-4.33M
16.62%-4.54M
-40.36%-5.88M
-42.52%-4.51M
-4.49%-4.96M
-40.67%-5.44M
-23.80%-4.19M
-39.60%-3.16M
-5.65%-4.75M
6.16%-3.87M
4.50%-3.38M
44.14%-2.26M
-93.93%-4.49M
-68.08%-4.12M
-22.25%-3.54M
-138.26%-4.05M
-177.95%-2.32M
Debt to assets ratio
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
Operating profit
28.67%-3.41M
28.72%-4.20M
16.02%-4.35M
13.99%-4.65M
16.71%-4.77M
-20.89%-5.90M
-47.00%-5.18M
-4.20%-5.41M
-33.73%-5.73M
-27.47%-4.88M
-64.25%-3.52M
-18.10%-5.19M
-5.41%-4.29M
-8.97%-3.83M
48.29%-2.15M
-77.28%-4.39M
-65.82%-4.07M
-21.24%-3.51M
-143.84%-4.15M
-197.46%-2.48M
Net Profit
26.62%-3.33M
30.65%-4.07M
7.29%-4.18M
12.67%-4.33M
16.62%-4.54M
-40.36%-5.88M
-42.52%-4.51M
-4.49%-4.96M
-40.67%-5.44M
-23.80%-4.19M
-39.60%-3.16M
-5.65%-4.75M
6.16%-3.87M
4.50%-3.38M
44.14%-2.26M
-93.93%-4.49M
-68.08%-4.12M
-22.25%-3.54M
-138.26%-4.05M
-177.95%-2.32M
Current assets
-66.11%7.06M
-57.21%10.80M
-55.01%13.46M
-51.26%17.20M
-47.24%20.82M
-41.75%25.25M
-36.91%29.92M
-30.86%35.29M
-28.45%39.47M
-26.19%43.34M
-23.53%47.43M
-22.27%51.04M
-18.47%55.17M
-19.24%58.72M
-18.75%62.02M
-20.05%65.66M
-17.97%67.66M
259.33%72.72M
239.65%76.34M
220.85%82.13M
Total current liabilities
-11.88%3.78M
3.93%4.50M
12.19%4.04M
6.16%4.88M
8.42%4.29M
61.72%4.33M
59.81%3.60M
52.55%4.60M
41.54%3.95M
-4.29%2.68M
-28.22%2.25M
-43.14%3.02M
-9.13%2.79M
20.30%2.80M
75.80%3.14M
97.32%5.30M
362.56%3.07M
321.15%2.33M
119.21%1.79M
18.07%2.69M
Total assets
-65.76%7.22M
-56.84%11.04M
-55.02%13.63M
-51.05%17.42M
-46.91%21.10M
-41.41%25.57M
-36.59%30.29M
-30.80%35.59M
-28.42%39.73M
-25.82%43.65M
-23.15%47.77M
-22.53%51.43M
-18.85%55.51M
-20.44%58.84M
-19.90%62.16M
-19.47%66.38M
-17.09%68.40M
263.22%73.95M
245.02%77.61M
221.84%82.43M
Total liabilities
-12.56%3.78M
2.68%4.50M
9.33%4.04M
5.21%4.90M
8.84%4.32M
60.02%4.38M
56.58%3.70M
47.01%4.66M
35.28%3.97M
-2.09%2.74M
-24.82%2.36M
-40.30%3.17M
-4.97%2.93M
17.62%2.80M
67.18%3.14M
88.17%5.30M
299.35%3.09M
260.01%2.38M
103.41%1.88M
18.18%2.82M
Total equity
-79.46%3.45M
-69.16%6.53M
-63.96%9.59M
-59.52%12.52M
-53.09%16.78M
-48.21%21.19M
-41.43%26.60M
-35.91%30.93M
-31.97%35.77M
-27.00%40.91M
-23.06%45.41M
-20.98%48.26M
-19.51%52.58M
-21.70%56.04M
-22.06%59.03M
-23.28%61.08M
-20.09%65.32M
263.33%71.57M
251.08%75.73M
242.75%79.61M
Net operating income
13.78%-3.77M
29.70%-2.79M
35.27%-3.61M
24.15%-3.94M
-42.60%-4.38M
-17.32%-3.97M
-54.54%-5.58M
-44.51%-5.19M
18.33%-3.07M
-26.85%-3.39M
10.55%-3.61M
-31.45%-3.59M
-12.90%-3.76M
-30.89%-2.67M
13.76%-4.04M
-58.37%-2.73M
-55.18%-3.33M
-30.04%-2.04M
-62.05%-4.68M
-251.52%-1.73M
Net investment
31.20%4.25M
-149.43%-1.70M
771.40%5.93M
1878.24%3.59M
682.44%3.24M
1245.63%3.45M
193.60%680.35K
55.81%-202.06K
42.12%-556.17K
-57.51%256.18K
411.61%231.73K
13.03%-457.24K
-644.35%-960.88K
357.68%602.86K
92.58%-74.36K
97.13%-525.75K
--176.52K
-4586.66%-233.96K
-30059.72%-1.00M
-233810.23%-18.29M
Net financing
----
--526.46K
12.07%13.44K
----
-100.00%0.00
100.00%0.00
--11.99K
--0.00
--54.72K
---500.00K
--0.00
--0.00
100.00%0.00
100.00%0.00
--0.00
100.00%0.00
-103.39%-2.18M
-334309.58%-872.81K
100.00%0.00
-100.00%-1.00

FAQs

What are the current assets of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its current assets were 10.80M, with a year-on-year change of -57.21.

What are the total assets of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its total assets of Lantern Pharma Inc were 11.04M, with a year-on-year change of -56.84.

What are the total liabilities of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its total liabilities of Lantern Pharma Inc were 4.50M, with a year-on-year change of 2.68.

What is the total equity of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its total equity of Lantern Pharma Inc was 6.53M, with a year-on-year change of -69.16.

What is the net operating income of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its net operating income of Lantern Pharma Inc was -17.98M, with a year-on-year change of 19.08.

What is the net investment of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its net investment of Lantern Pharma Inc was 11.06M, with a year-on-year change of 228.16.

What is the net financing of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its net financing of Lantern Pharma Inc was 1.50M, with a year-on-year change of 2145.90.

What is the Earnings Per Share (EPS) of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.57, with a year-on-year change of 18.65.

What is the net income of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its net income was -17.12M, with a year-on-year change of 17.62.

What is the Return on Equity (ROE) of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -123.51, with a year-on-year change of -84.53.

What is the Return on Assets (ROA) of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -93.53, with a year-on-year change of -55.77.

What is the operating profit of Lantern Pharma Inc?

According to Lantern Pharma Inc's FY2025 earnings report, its operating profit was -17.98M, with a year-on-year change of 19.08.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.